RadioMedix, Inc. Sustainability Profile
RadioMedix, Inc., headquartered in the United States, is a pioneering force in the radiopharmaceutical industry, specialising in the development and commercialisation of innovative diagnostic and therapeutic solutions. Founded in 2011, the company has made significant strides in advancing targeted radiotherapy, particularly in oncology, with a focus on improving patient outcomes. With a robust portfolio of unique products, including radiolabelled agents for imaging and treatment, RadioMedix stands out for its commitment to precision medicine. The company operates primarily in North America, with expanding influence in global markets. Recognised for its cutting-edge research and development, RadioMedix has established a strong market position, contributing to the evolution of personalised cancer care through its state-of-the-art technologies.
DitchCarbon Score
How does RadioMedix, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RadioMedix, Inc.'s score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
RadioMedix, Inc.'s reported carbon emissions
RadioMedix, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As there are no emissions or reduction initiatives reported, it is unclear how RadioMedix, Inc. is addressing its carbon footprint or contributing to climate action within its industry. The lack of data may suggest an opportunity for the company to develop and communicate its climate commitments more effectively, aligning with broader industry trends towards sustainability and emissions reduction.
How Carbon Intensive is RadioMedix, Inc.'s Industry?
How Carbon Intensive is RadioMedix, Inc.'s Location?
RadioMedix, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
RadioMedix, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
